Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of hydroxyethyl starch solutions on blood coagulation after cardiac surgery
2005-005315-17Phase 4Completed
- Sponsor
- Tomi Niemi
- Start
- Nov 2005
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of Volulyte, hetastarch and albumin (human) in coronary arteriosclerosis (3 arms), sponsored by Tomi Niemi. Primary endpoint: Maximum clot strength by thromboelastography. Started Nov 2005; status: completed.
02
Drugs
Volulytehetastarchalbumin (human)
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2005-005315-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005315-17.